Bing He
Impact in
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 28
- Lipid Membrane Structure and Behavior 11
- Advanced biosensing and bioanalysis techniques 10
- Biomaterials 52
- Nanoparticle-Based Drug Delivery 50
- Co-authors
- Xueqing Wang (89 shared papers)Wenbing Dai (89 shared papers)Qiang Zhang (77 shared papers)Hua Zhang (67 shared papers)Jiancheng Wang (16 shared papers)Binlong Chen (14 shared papers)Xuan Zhang (10 shared papers)Lan Yuan (17 shared papers)
- Journals
- Journal of Controlled Release (13 papers)Biomaterials (12 papers)Molecular Pharmaceutics (6 papers)Acta Pharmaceutica Sinica B (5 papers)ACS Nano (5 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Bing He
137 papers receiving 5.3k citations
Peers
Comparison fields: 5 of 140
- Biomaterials 2.0k
- Pharmaceutical Science 692
- Biomedical Engineering 1.8k
- Molecular Medicine 175
- Molecular Biology 2.2k
Countries citing papers authored by Bing He
This map shows the geographic impact of Bing He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing He more than expected).
Fields of papers citing papers by Bing He
This network shows the impact of papers produced by Bing He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing He. The network helps show where Bing He may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 279 | |
| 2 | 2013 | 194 | |
| 3 | 2013 | 177 | |
| 4 | 2020 | 165 | |
| 5 | 2019 | 148 | |
| 6 | 2016 | 138 | |
| 7 | 2016 | 127 | |
| 8 | 2012 | 126 | |
| 9 | 2017 | 119 | |
| 10 | 2015 | 116 | |
| 11 | 2013 | 109 | |
| 12 | 2015 | 108 | |
| 13 | 2013 | 105 | |
| 14 | 2018 | 105 | |
| 15 | 2014 | 101 | |
| 16 | 2013 | 88 | |
| 17 | 2014 | 87 | |
| 18 | 2014 | 83 | |
| 19 | 2015 | 79 | |
| 20 | 2014 | 77 |
About Bing He
Bing He is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Oncology and Pulmonary and Respiratory Medicine, having authored 141 papers that have together received 5.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (50 papers), RNA Interference and Gene Delivery (28 papers), Nanoplatforms for cancer theranostics (25 papers), Cell Adhesion Molecules Research (11 papers), Lipid Membrane Structure and Behavior (11 papers), Dendrimers and Hyperbranched Polymers (10 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Advanced Drug Delivery Systems (9 papers). The work is most often cited by research in Biomaterials (2.0k citations), Pharmaceutical Science (692 citations), Biomedical Engineering (1.8k citations), Molecular Medicine (175 citations) and Molecular Biology (2.2k citations). Bing He has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Xueqing Wang, Wenbing Dai, Qiang Zhang, Hua Zhang, Jiancheng Wang, Binlong Chen, Xuan Zhang, Lan Yuan, Yiguang Wang and Hailiang Deng. Their work appears in journals such as Journal of Controlled Release, Biomaterials, Molecular Pharmaceutics, Acta Pharmaceutica Sinica B and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.